Global Mycoprotein Market Strategic Research Report
By Type: Food Grade Mycoprotein, Feed Grade Mycoprotein
By Application: Meat Alternatives, Pet Food, Feed
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Marlow Foods Limited (GB), ENOUGH (GB), Meati Foods (US), Nature’s Fynd (US), The Better Meat Co. (US), Naplasol (BE), Infinite Roots (DE), MycoTechnology, Inc. (US)
Visão geral
Scope of the Report
The global Mycoprotein market size is predicted to grow from US$ 704 million in 2025 to US$ 1,071 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
Mycoprotein—also known as fungal protein—is produced using edible filamentous fungi or mycelium as the primary biological agent. Through food-grade fermentation processes, substrates such as sugars, grain syrups, starch hydrolysates, or plant-based by-products are converted into protein-rich, high-fiber alternative protein ingredients. These are commonly used in meat analogues, hybrid meat products, plant-based seafood, dairy alternatives, nutritional fortification in baked goods, protein powders, foodservice ingredients, pet food, and certain animal feed formulations. In 2025, global sales volume reached approximately 118,000 metric tons, with an average unit price of around $6,100 per ton and a global capacity utilization rate of approximately 68.5%. Upstream industry players include manufacturers of glucose syrup and starch-based sugars, grain processors, fermentation strain developers, fermentation equipment manufacturers, suppliers of food-grade nutrients and additives, cold-chain packaging companies, and food safety testing agencies. Downstream players comprise plant-based meat brands, frozen food companies, restaurant chains, food ingredient companies, pet food manufacturers, nutritional food brands, retailers, and institutional catering providers; the industry's average gross profit margin is approximately 36.8%. Regarding the cost structure, carbon sources and culture medium raw materials account for approximately 22%, strain maintenance and fermentation nutrients for 7%, fermentation energy consumption and steam for 13%, and equipment depreciation and maintenance for 10%. Labor and factory management account for approximately 9%; dehydration, molding, and texturization for 11%; seasonings, additives, and blended ingredients for 8%; packaging, cold chain, and warehousing/logistics for 10%; testing, quality control, and food safety compliance for 5%; and R&D and other expenses for 5%. The demand list encompasses requirements for plant-based meat bases, whole-cut meat alternatives, fat-reduced blended meat products, plant-based seafood, dairy alternatives, nutritional protein ingredients, pet food proteins, and customized foodservice formulations. Downstream clients include plant-based meat companies, frozen food manufacturers, restaurant chains, ingredient distributors, food processors, pet food manufacturers, nutritional powder brands, retail private-label brands, and institutional catering clients (schools and enterprises). Business opportunities are driven by policies promoting low-carbon food systems, sustainable protein investment, improved food safety regulation, innovation in alternative proteins, and efficient agricultural resource utilization; by technological innovations such as high-yield strain screening, continuous fermentation, low-cost culture media, mycelium structural integrity, dehydration and texturization, flavor masking, and high-protein powder production; and by shifting consumer demands—moving from simple vegetarian substitutes to a comprehensive preference for high-protein, low-fat, and low-cholesterol products that offer authentic meat-like texture, clean labels, and a low carbon footprint, all at price points comparable to conventional meat.
Mycoprotein represents one of the most commercially established segments within the fungal fermentation protein sector, with global sales projected to reach approximately 118,000 tonnes by 2025. Demand is concentrated primarily in Europe and North America; the European market is characterized by mature brands and ingredient-focused production, whereas the North American market is driven by food-tech brands, whole-cut mycelium products, and foodservice trials. Compared to plant-based proteins such as soy and pea protein, mycoprotein’s core advantage lies in the natural fibrous structure of its mycelium, which closely mimics the texture and mouthfeel of meat. Additionally, it offers a nutritional profile rich in protein and dietary fiber while remaining low in fat and cholesterol. Its formulation requires less reliance on extrusion-based texturization and various additives, offering unique value in applications such as meat alternatives, hybrid meat products, functional proteins, and pet food. However, the industry currently faces constraints including high capital investment for fermentation capacity, elevated unit costs, price sensitivity at the retail level, limited consumer awareness regarding fungal-derived proteins, lengthy regulatory approval processes, and high cold-chain logistics costs. Over the next two to five years, industry growth will hinge not merely on expanding the vegetarian consumer base, but on securing acceptance among flexitarians, foodservice providers, and food manufacturers for its use as a stable ingredient. The market is poised for rapid growth if companies can successfully reduce cultivation medium costs, improve fermentation yields, and maximize capacity utilization, while simultaneously expanding product applications beyond premium retail to include B2B ingredients, hybrid meat products, institutional catering, pet food, and nutritional fortification. Overall, the industry remains in a growth phase where leading players currently enjoy a first-mover advantage; however, medium- to long-term competition will shift toward fermentation efficiency, cost control, textural performance, regulatory compliance, and the ability to tailor formulations to specific customer needs.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mycoprotein market?
What factors are driving Mycoprotein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mycoprotein market opportunities vary by end market size?
How does Mycoprotein break out by Type, by Application?
This report presents a comprehensive overview of the global Mycoprotein market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Food Grade Mycoprotein
- Feed Grade Mycoprotein
Segment by Dry Basis Protein Content
- <25%
- 25%-45%
- >45%
Segment by Microbial Source
- Yeast-Based
- Mold-Based
- Other
Segment by Application
- Meat Alternatives
- Pet Food
- Feed
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Mycoprotein market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Meat Alternatives, Pet Food, Feed evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Mycoprotein Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Food Grade Mycoprotein
- 3.1.3 Feed Grade Mycoprotein
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Meat Alternatives
- 4.1.3 Pet Food
- 4.1.4 Feed
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Marlow Foods Limited (GB)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 ENOUGH (GB)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Meati Foods (US)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Nature’s Fynd (US)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 The Better Meat Co. (US)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Naplasol (BE)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Infinite Roots (DE)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 MycoTechnology, Inc. (US)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Mycoprotein market size?
What growth rate is expected for the Mycoprotein market through 2032?
How is Mycoprotein defined?
How is the Mycoprotein market segmented by type?
What are the key applications of Mycoprotein?
Which companies are profiled in the Mycoprotein market report?
What geographies does the Mycoprotein market analysis include?
What are the key demand drivers for Mycoprotein?
What are the main risks and barriers in the Mycoprotein market?
Who should buy the Mycoprotein market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Mycoprotein Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Consumer Goods & Retail